Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA

Area of Science:

• Immunology
• Neuroendocrinology
• Molecular Biology

Background:

• Vasoactive intestinal peptide (VIP) is a neuropeptide found in lymphoid organs.
• VIP is known to inhibit T-cell proliferation and cytokine production (IL-2, IL-4).
• VIP's immunoregulatory effects are thought to be mediated by specific VIP-binding sites on lymphocytes.

Purpose of the Study:

• To investigate the expression of the VIP-R1 receptor mRNA in different murine lymphocyte subpopulations.
• To determine if VIP-R1 is present in lymphocytes involved in immune responses.

Main Methods:

• Reverse Transcription Polymerase Chain Reaction (RT-PCR)
• RNase protection assay
• cDNA cloning and sequence analysis

Main Results:

• VIP-R1 mRNA was detected in both stimulated and unstimulated murine spleen cells, thymocytes, CD4+ T-cells, and CD8+ T-cells.
• The nucleotide sequences of VIP-R1 from murine brain, thymocytes, spleen cells, and CD4+ T-cells showed high homology with rat and human sequences.
• VIP-R1 is expressed in thymocytes and peripheral lymphocytes, particularly in the CD4+ T-cell subset.

Conclusions:

• The presence of VIP-R1 in thymocytes and peripheral lymphocytes, especially CD4+ T-cells, suggests VIP can directly influence T-cell cytokine production and proliferation.
• These findings support a role for locally produced or released VIP in modulating immune responses within the lymphoid microenvironment.